Castle Biosciences Inc (CSTL) Quality Analysis

CSTL GoodMoat Verdict

Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.

Run Stock X-Ray →

CSTL Profitability

Profitability trend analysis coming soon

CSTL Growth

Growth trend analysis coming soon

CSTL Financial Health

Financial health indicators coming soon

CSTL Quality & Fundamental Analysis

Castle Biosciences Inc (CSTL) is a Healthcare company in the Diagnostics & Research industry, listed on NASDAQ. This quality analysis page evaluates Castle Biosciences Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.

Castle Biosciences Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of -3.78% and a return on equity (ROE) of -2.73%. Return on assets (ROA) stands at -2.22%.

The debt-to-equity ratio is 0.08, with a current ratio of 5.26. Operating margin is -12.44%.

GoodMoat's quality analysis uses AI-powered insights to evaluate whether Castle Biosciences Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.